You have 9 free searches left this month | for more free features.

Squamous Cell Carcinoma of Head and Neck

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

Not yet recruiting
  • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Oct 24, 2023

Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Carrilizumab, bevacizumab,capecitabine
  • (no location specified)
Jul 20, 2023

Head and Neck Squamous-cell Carcinoma

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
    • (no location specified)
    Nov 5, 2023

    Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital, School of Medicine, Zhejiang Univers
      Aug 22, 2023

      Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +3 more
      • Guangzhou, Guangdong, China
      • +4 more
      Nov 16, 2023

      Needs and Preferences of Patients With Head-neck Cutaneous SCC

      Active, not recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +10 more
      • Regular care with additional administration of a semi-structured interview
      • Maastricht, Netherlands
        Maastricht University Medical Center+
      Sep 13, 2023

      Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Aug 17, 2023

      Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

      Not yet recruiting
      • Locally Advanced Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Mar 20, 2023

      Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Locally Advanced Operable
      • Guangzhou, Guangdong, China
      • +1 more
      Sep 4, 2023

      Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • PET/CT
      • Neck dissection
      • (no location specified)
      Jan 31, 2023

      Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Head and Neck Cancer
      • (no location specified)
      Jun 9, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Nab paclitaxel
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital
      Aug 24, 2023

      Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,

      Not yet recruiting
      • Metastatic Head-and-neck Squamous-cell Carcinoma
      • Recurrent Head and Neck Squamous Cell Carcinoma
      • Ficlatuzumab
      • +2 more
      • (no location specified)
      Sep 26, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Zanzalintinib, Zanzalintinib-matched Placebo, Pembrolizumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Oct 9, 2023

      Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Chengdu (Netopitam Palonosetron capsules and dexamethasone)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma (HNSCC)
      • Netopitam Palonosetron capsules and dexamethasone
      • Chengdu, Sichuan, China
        Sichuan Cancer Hospital and Research Institute
      Oct 22, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Penpulimab injection
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
      Oct 7, 2023

      Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity
      • +3 more
      • Eliminating RT to the elective neck
      • RT standard of care
      • Erlangen, Bavaria, Germany
        Universitätsklinikum Erlangen, Strahlenklinik
      Sep 8, 2023

      Prognostic Immune Biomarkers in HNSCC

      Completed
      • Head and Neck Cancer
      • Squamous Cell Carcinoma
      • Tumour immunoprofile evaluation
      • Ostrava, Moravian-Silesian Region, Czechia
        University Hospital Ostrava
      Jul 3, 2023

      Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)

      Not yet recruiting
      • Head Neck
      • Squamous Cell Carcinoma of Head and Neck
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 14, 2023

      Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

      Not yet recruiting
      • Recurrent Head and Neck Cancer
      • +5 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 30, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Oct 25, 2023

      Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)

      Not yet recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • fMRI
      • Oral Pimonidazole
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Center
      Oct 9, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 17, 2023

      Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
      • Black Raspberry
      • (no location specified)
      Oct 16, 2023